Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: A perspective from the Hunter Outcome Survey (HOS)
Authors:
- Barbara K. BurtonBBBarbara K. Burton
- David A.H. WhitemanDWDavid A.H. Whiteman
- 1 June 2011
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 103 (2) , 113-120
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II — data from the Hunter Outcome SurveyMolecular Genetics and Metabolism, 2010
- Multidisciplinary Management of Hunter SyndromePediatrics, 2009
- Long-term Efficacy and Safety of Laronidase in the Treatment of Mucopolysaccharidosis IPediatrics, 2009
- Home treatment with Elaprase® and Naglazyme® is safe in patients with mucopolysaccharidoses types II and VI, respectivelyJournal of Inherited Metabolic Disease, 2008
- Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapyEuropean Journal of Pediatrics, 2007
- Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension studyThe Journal of Pediatrics, 2006
- Biphasic anaphylactic reactionsAnnals of Allergy, Asthma & Immunology, 2005
- Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (laronidase)The Journal of Pediatrics, 2004
- Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis IThe Lancet, 2003
- THE NATURAL HISTORY OF THE SEVERE FORM OF HUNTER'S SYNDROME: A STUDY BASED ON 52 CASESDevelopmental Medicine & Child Neurology, 1983